FY2025 EPS Estimates for Transcat, Inc. Decreased by HC Wainwright (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Investment analysts at HC Wainwright lowered their FY2025 earnings estimates for shares of Transcat in a research note issued on Wednesday, May 22nd. HC Wainwright analyst S. Buck now forecasts that the scientific and technical instruments company will earn $1.88 per share for the year, down from their previous estimate of $2.31. HC Wainwright currently has a "Buy" rating and a $156.00 target price on the stock. The consensus estimate for Transcat's current full-year earnings is $1.98 per share.

TRNS has been the topic of a number of other research reports. Oppenheimer increased their price objective on shares of Transcat from $125.00 to $160.00 and gave the stock an "outperform" rating in a research note on Wednesday. TheStreet raised shares of Transcat from a "c+" rating to a "b" rating in a report on Wednesday, January 31st. Northland Capmk downgraded shares of Transcat from a "strong-buy" rating to a "hold" rating in a report on Wednesday. Finally, Northland Securities downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, Transcat has a consensus rating of "Hold" and an average price target of $134.50.

Transcat Stock Performance

Shares of NASDAQ:TRNS traded up $0.04 during midday trading on Friday, reaching $134.51. The company's stock had a trading volume of 34,111 shares, compared to its average volume of 39,776. The firm has a market capitalization of $1.19 billion, a PE ratio of 84.60 and a beta of 0.61. Transcat has a twelve month low of $81.26 and a twelve month high of $147.00. The stock has a fifty day moving average of $114.10 and a 200 day moving average of $106.47. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01.

Hedge Funds Weigh In On Transcat

Several institutional investors have recently bought and sold shares of the company. State Board of Administration of Florida Retirement System acquired a new position in shares of Transcat during the 3rd quarter worth $207,000. Arizona State Retirement System acquired a new position in shares of Transcat during the 3rd quarter worth $213,000. Virtu Financial LLC acquired a new position in shares of Transcat during the 1st quarter worth $224,000. Quantbot Technologies LP grew its stake in shares of Transcat by 118.2% during the 3rd quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company's stock worth $232,000 after purchasing an additional 1,284 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Transcat by 13.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company's stock worth $262,000 after purchasing an additional 284 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Transcat

In other news, CEO Lee D. Rudow sold 3,343 shares of the business's stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the completion of the sale, the chief executive officer now owns 103,692 shares in the company, valued at approximately $12,870,251.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Lee D. Rudow sold 3,343 shares of the business's stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the completion of the sale, the chief executive officer now owns 103,692 shares in the company, valued at approximately $12,870,251.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lee D. Rudow sold 12,000 shares of the business's stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $135.10, for a total transaction of $1,621,200.00. Following the sale, the chief executive officer now owns 91,692 shares of the company's stock, valued at approximately $12,387,589.20. The disclosure for this sale can be found here. Insiders sold a total of 17,716 shares of company stock worth $2,300,557 over the last three months. Insiders own 4.20% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.